Expression of cyclo-oxygenase-2 and yap/taz in hepatocellular carcinoma in untreated and treated hepatitis C virus patients
The pathogenesis of hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC) differs according to whether prior treatment with interferon (IFN) vs. direct-acting antiviral agents (DAAs) was administered. Cyclo- oxygenase-2 (COX-2), yes-associated protein 1 (YAP), and transcriptional co-activat...
Main Authors: | Dina Sweed, Aya Abd-Elbary, Eman Sweed, Asmaa Mosbeh, Inas Moaz, Taha Yassein, Shereen Elmashad |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2022-08-01
|
Series: | Polish Journal of Pathology |
Subjects: | |
Online Access: | https://www.termedia.pl/Expression-of-cyclo-oxygenase-2-and-yap-taz-in-hepatocellular-carcinoma-in-untreated-and-treated-hepatitis-C-virus-patients,55,47623,1,1.html |
Similar Items
-
YAP/TAZ Activation as a Target for Treating Metastatic Cancer
by: Janine S. A. Warren, et al.
Published: (2018-04-01) -
YAP/TAZ: Molecular pathway and disease therapy
by: Yuzi Wei, et al.
Published: (2023-08-01) -
Roles of Hippo–YAP/TAZ signalling in intervertebral disc degeneration
by: Shi Zheng-wei, et al.
Published: (2023-03-01) -
Denervation Drives YAP/TAZ Activation in Muscular Fibro/Adipogenic Progenitors
by: Felipe S. Gallardo, et al.
Published: (2023-03-01) -
Identification of a Gene Signature That Predicts Dependence upon YAP/TAZ-TEAD
by: Ryan Kanai, et al.
Published: (2024-02-01)